» Articles » PMID: 3813869

Effect of Altered Volume of Distribution on Aminoglycoside Levels in Patients in Surgical Intensive Care

Overview
Journal Arch Surg
Specialty General Surgery
Date 1987 Feb 1
PMID 3813869
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

The apparent volume of distribution (Vd) of aminoglycosides was found to be increased in 100 patients in a surgical intensive care unit who had gram-negative pneumonia or intraabdominal sepsis and acute physiologic scores greater than 12. Following loading or maintenance doses, carefully timed blood samples were collected for measurements of serum concentrations by fluorescence polarization immunoassay. The Vd, determined by linear regression analysis of a one-compartment model using the Sawchuk-Zaske method, was 0.34 +/- 0.121 L/kg and was larger than the normal Vd of 0.20 to 0.25 L/kg, suggesting a 36% to 70% increase in extracellular fluid volume. Since there is a predictable increase in aminoglycoside Vd in the septic surgical patient, a proportionately larger aminoglycoside dosage is required initially to achieve desirable peak serum levels. Close monitoring of blood levels during maintenance dosing is suggested since dynamic changes in renal function and aminoglycoside Vd occur in the critically ill.

Citing Articles

The relation between inflammatory biomarkers and drug pharmacokinetics in the critically ill patients: a scoping review.

Li L, Zinger J, Sassen S, Juffermans N, Koch B, Endeman H Crit Care. 2024; 28(1):376.

PMID: 39563441 PMC: 11577668. DOI: 10.1186/s13054-024-05150-4.


Recommendations of Gentamicin Dose Based on Different Pharmacokinetic/Pharmacodynamic Targets for Intensive Care Adult Patients: A Redefining Approach.

Abbasi M, Chaijamorn W, Wiwattanawongsa K, Charoensareerat T, Doungngern T Clin Pharmacol. 2023; 15:67-76.

PMID: 37427084 PMC: 10329437. DOI: 10.2147/CPAA.S417298.


Challenges in Individualizing Drug Dosage for Intensive Care Unit Patients: Is Augmented Renal Clearance What We Really Want to Know? Some Suggested Management Approaches and Clinical Software Tools.

Jelliffe R Clin Pharmacokinet. 2016; 55(8):897-905.

PMID: 26914772 DOI: 10.1007/s40262-016-0369-4.


Does Beta-lactam Pharmacokinetic Variability in Critically Ill Patients Justify Therapeutic Drug Monitoring? A Systematic Review.

Sime F, Roberts M, Peake S, Lipman J, Roberts J Ann Intensive Care. 2012; 2(1):35.

PMID: 22839761 PMC: 3460787. DOI: 10.1186/2110-5820-2-35.


Tobramycin disposition in ICU patients receiving a once daily regimen: population approach and dosage simulations.

Conil J, Georges B, Ruiz S, Rival T, Seguin T, Cougot P Br J Clin Pharmacol. 2010; 71(1):61-71.

PMID: 21143502 PMC: 3018027. DOI: 10.1111/j.1365-2125.2010.03793.x.